In a filing, Akero Therapeutics Inc revealed its Chief Operating Officer Young Jonathan unloaded Company’s shares for reported $0.28 million on Jan 02 ’25. In the deal valued at $28.03 per share,10,000 shares were sold. As a result of this transaction, Young Jonathan now holds 218,083 shares worth roughly $5.58 million.
Then, Jonathan Young bought 70,000 shares, generating $1,947,400 in total proceeds.
Before that, Lamy Patrick sold 1,000 shares. Akero Therapeutics Inc shares valued at $29,130 were divested by the Senior VP, Commercial Strategy at a price of $29.13 per share. As a result of the transaction, Lamy Patrick now holds 34,258 shares, worth roughly $0.88 million.
Citigroup initiated its Akero Therapeutics Inc [AKRO] rating to a Buy in a research note published on November 18, 2024; the price target was $65. Cantor Fitzgerald began covering AKRO with “an Overweight” recommendation on September 19, 2023. UBS started covering the stock on August 28, 2023. It rated AKRO as “a Buy”.
Price Performance Review of AKRO
On Tuesday, Akero Therapeutics Inc [NASDAQ:AKRO] saw its stock jump 1.83% to $25.60. Over the last five days, the stock has gained 13.12%. Akero Therapeutics Inc shares have fallen nearly -7.98% since the year began. Nevertheless, the stocks have risen 18.68% over the past one year. While a 52-week high of $37.00 was reached on 01/06/25, a 52-week low of $15.32 was recorded on 01/14/25. SMA at 50 days reached $29.30, while 200 days put it at $25.93.
Levels Of Support And Resistance For AKRO Stock
The 24-hour chart illustrates a support level at 25.17, which if violated will result in even more drops to 24.73. On the upside, there is a resistance level at 26.12. A further resistance level may holdings at 26.63. The Relative Strength Index (RSI) on the 14-day chart is 44.22, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.72, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 43.95%. Stochastics %K at 51.80% indicates the stock is a holding.
How much short interest is there in Akero Therapeutics Inc?
A steep rise in short interest was recorded in Akero Therapeutics Inc stocks on 2024-12-31, growing by 22077.0 shares to a total of 3.31 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-29 was 3.29 million shares. There was a rise of 0.67%, which implies that there is a positive sentiment for the stock.
